Skip to main content
. 2016 Jan 29;8:4. doi: 10.1186/s13195-016-0173-2

Fig. 2.

Fig. 2

Panel a shows the difference in mean amyloid burden and 95 % confidence intervals for changes from baseline at 4 weeks between bexarotene and placebo groups. Panel b shows mean group changes and 95 % confidence intervals at 4 weeks. P-values reflect the comparisons of mean change between groups